Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Silverback Therapeutics Inc

SPRY
Current price
14.01 USD -0.18 USD (-1.27%)
Last closed 14.11 USD
ISIN US82835W1080
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 651 884 928 USD
Yield for 12 month +210.64 %
1Y
3Y
5Y
10Y
15Y
SPRY
21.11.2021 - 28.11.2021

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California. Address: 11682 El Camino Real, San Diego, CA, United States, 92130

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

25.67 USD

P/E ratio

Dividend Yield

Current Year

+30 000 USD

Last Year

+1 316 000 USD

Current Quarter

+500 000 USD

Last Quarter

Current Year

-43 000 USD

Last Year

-16 004 000 USD

Current Quarter

+482 000 USD

Last Quarter

-11 000 USD

Key Figures SPRY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -56 674 000 USD
Operating Margin TTM -3068 %
PE Ratio
Return On Assets TTM -14.75 %
PEG Ratio
Return On Equity TTM -19.34 %
Wall Street Target Price 25.67 USD
Revenue TTM 500 000 USD
Book Value 2.22 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 4900 %
Dividend Yield
Gross Profit TTM 1 316 000 USD
Earnings per share -0.47 USD
Diluted Eps TTM -0.47 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SPRY

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SPRY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation SPRY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2866.602
Price Sales TTM 3303.7698
Enterprise Value EBITDA -9.8781
Price Book MRQ 7.6746

Financials SPRY

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SPRY

For 52 weeks

4.01 USD 18.51 USD
50 Day MA 14.3 USD
Shares Short Prior Month 11 097 485
200 Day MA 10.56 USD
Short Ratio 12.65
Shares Short 11 915 667
Short Percent 23.16 %